In MPN, NGS confirmed diagnoses in 16 cases by detecting JAK2, MPL, or CALR mutations, whereas 13 “triple-negative” MPN cases revealed at least 1 mutation. This evidence concerns the gene CALR and myeloproliferative neoplasm.